The University of Chicago Header Logo

Connection

Mark Talamonti to Liver Neoplasms

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Liver Neoplasms.
Mark Talamonti
Connection Strength
1.820
Liver Neoplasms
  1. Endovascular management of portal vein obstruction in hepatobiliary cancer patients. J Surg Oncol. 2022 Mar; 125(3):392-398.
    View in: PubMed
    Score: 0.494
  2. The minimally invasive approach confers improved outcomes in frail cancer patients undergoing hepatectomy: an American College of Surgeons National Surgical Quality Improvement Program analysis. J Gastrointest Surg. 2024 Jul; 28(7):1017-1026.
    View in: PubMed
    Score: 0.147
  3. Integrated Clinical-Molecular Classification of Colorectal Liver Metastases: A Biomarker Analysis of the Phase 3 New EPOC Randomized Clinical Trial. JAMA Oncol. 2023 09 01; 9(9):1245-1254.
    View in: PubMed
    Score: 0.141
  4. Number of Hepatic Resections and Association with Complication after Metastatic Neuroendocrine Tumor Debulking: An American College of Surgeons NSQIP Database Study. J Am Coll Surg. 2023 07 01; 237(1):157-168.
    View in: PubMed
    Score: 0.137
  5. Risk factors and outcomes in patients undergoing minimally invasive hepatectomy with unplanned conversion: a contemporary NSQIP analysis. HPB (Oxford). 2023 05; 25(5):577-588.
    View in: PubMed
    Score: 0.135
  6. Clinical features of primary and metastatic hepatic malignancies. Cancer Treat Res. 2001; 109:1-14.
    View in: PubMed
    Score: 0.117
  7. Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. Nat Commun. 2018 05 04; 9(1):1793.
    View in: PubMed
    Score: 0.097
  8. Liver transplant offers a survival benefit over margin negative resection in patients with small unifocal hepatocellular carcinoma and preserved liver function. Surgery. 2018 03; 163(3):582-586.
    View in: PubMed
    Score: 0.095
  9. Local-regional therapy for metastatic liver tumors. Cancer Treat Res. 1998; 98:172-99.
    View in: PubMed
    Score: 0.095
  10. Management of Incidental Liver Lesions on CT: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2017 Nov; 14(11):1429-1437.
    View in: PubMed
    Score: 0.093
  11. Orthotopic liver transplantation provides a survival advantage compared with resection in patients with hepatocellular carcinoma and preserved liver function. Surgery. 2017 11; 162(5):1032-1039.
    View in: PubMed
    Score: 0.093
  12. Radioembolization of colorectal hepatic metastases using yttrium-90 microspheres. Cancer. 2009 May 01; 115(9):1849-58.
    View in: PubMed
    Score: 0.052
  13. Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival. Radiology. 2008 May; 247(2):507-15.
    View in: PubMed
    Score: 0.048
  14. Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors. Surgery. 2001 Oct; 130(4):677-82; discussion 682-5.
    View in: PubMed
    Score: 0.031
  15. Phase II trial of chemoembolization for the treatment of metastatic colorectal carcinoma to the liver and review of the literature. Cancer. 1998 Apr 01; 82(7):1250-9.
    View in: PubMed
    Score: 0.024
  16. Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. J Clin Invest. 1993 Jan; 91(1):53-60.
    View in: PubMed
    Score: 0.017
  17. Site-specific differences in pp60c-src activity in human colorectal metastases. J Surg Res. 1993 Apr; 54(4):293-8.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.